Results
|
1881.
|
Association of several lipid-related gene polymorphisms and blood pressure variation in the Bai Ku Yao population. [electronic resource] by
- Yin, Rui-Xing
- Wu, Jin-Zhen
- Liu, Wan-Ying
- Wu, Dong-Feng
- Cao, Xiao-Li
- Miao, Lin
- Htet Aung, Lynn Htet
- Zhang, Lin
- Long, Xing-Jiang
- Li, Meng
- Pan, Shang-Ling
Producer: 20121203
In:
American journal of hypertension vol. 25
Availability: No items available.
|
|
1882.
|
|
|
1883.
|
G-protein estrogen receptor as a regulator of low-density lipoprotein cholesterol metabolism: cellular and population genetic studies. [electronic resource] by
- Hussain, Yasin
- Ding, Qingming
- Connelly, Philip W
- Brunt, J Howard
- Ban, Matthew R
- McIntyre, Adam D
- Huff, Murray W
- Gros, Robert
- Hegele, Robert A
- Feldman, Ross D
Producer: 20150223
In:
Arteriosclerosis, thrombosis, and vascular biology vol. 35
Availability: No items available.
|
|
1884.
|
Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial. [electronic resource] by
- Schwartz, Gregory G
- Bessac, Laurence
- Berdan, Lisa G
- Bhatt, Deepak L
- Bittner, Vera
- Diaz, Rafael
- Goodman, Shaun G
- Hanotin, Corinne
- Harrington, Robert A
- Jukema, J Wouter
- Mahaffey, Kenneth W
- Moryusef, Angèle
- Pordy, Robert
- Roe, Matthew T
- Rorick, Tyrus
- Sasiela, William J
- Shirodaria, Cheerag
- Szarek, Michael
- Tamby, Jean-François
- Tricoci, Pierluigi
- White, Harvey
- Zeiher, Andreas
- Steg, Philippe Gabriel
Producer: 20150124
In:
American heart journal vol. 168
Availability: No items available.
|
|
1885.
|
|
|
1886.
|
AMG 145, a monoclonal antibody against PCSK9, facilitates achievement of national cholesterol education program-adult treatment panel III low-density lipoprotein cholesterol goals among high-risk patients: an analysis from the LAPLACE-TIMI 57 trial (LDL-C assessment with PCSK9 monoclonal antibody inhibition combined with statin thErapy-thrombolysis in myocardial infarction 57). [electronic resource] by
- Desai, Nihar R
- Giugliano, Robert P
- Zhou, Jing
- Kohli, Payal
- Somaratne, Ransi
- Hoffman, Elaine
- Liu, Thomas
- Scott, Robert
- Wasserman, Scott M
- Sabatine, Marc S
Producer: 20140415
In:
Journal of the American College of Cardiology vol. 63
Availability: No items available.
|
|
1887.
|
Independent Link Between Levels of Proprotein Convertase Subtilisin/Kexin Type 9 and FABP4 in a General Population Without Medication. [electronic resource] by
- Furuhashi, Masato
- Omori, Akina
- Matsumoto, Megumi
- Kataoka, Yu
- Tanaka, Marenao
- Moniwa, Norihito
- Ohnishi, Hirofumi
- Yoshida, Hideaki
- Saitoh, Shigeyuki
- Shimamoto, Kazuaki
- Miura, Tetsuji
Producer: 20170501
In:
The American journal of cardiology vol. 118
Availability: No items available.
|
|
1888.
|
Familial Hypercholesterolemia Phenotype in Chinese Patients Undergoing Coronary Angiography. [electronic resource] by
- Li, Jian-Jun
- Li, Sha
- Zhu, Cheng-Gang
- Wu, Na-Qiong
- Zhang, Yan
- Guo, Yuan-Lin
- Gao, Ying
- Li, Xiao-Lin
- Qing, Ping
- Cui, Chuan-Jue
- Xu, Rui-Xia
- Jiang, Zheng-Wen
- Sun, Jing
- Liu, Geng
- Dong, Qian
Producer: 20170621
In:
Arteriosclerosis, thrombosis, and vascular biology vol. 37
Availability: No items available.
|
|
1889.
|
|
|
1890.
|
|
|
1891.
|
|
|
1892.
|
Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy. [electronic resource] by
- Cho, Leslie
- Rocco, Michael
- Colquhoun, David
- Sullivan, David
- Rosenson, Robert S
- Dent, Ricardo
- Xue, Allen
- Scott, Rob
- Wasserman, Scott M
- Stroes, Erik
Producer: 20141110
In:
Clinical cardiology vol. 37
Availability: No items available.
|
|
1893.
|
Treatment with PCSK9 inhibitors reduces atherogenic VLDL remnants in a real-world study. [electronic resource] by
- Hollstein, Tim
- Vogt, Anja
- Grenkowitz, Thomas
- Stojakovic, Tatjana
- März, Winfried
- Laufs, Ulrich
- Bölükbasi, Bediha
- Steinhagen-Thiessen, Elisabeth
- Scharnagl, Hubert
- Kassner, Ursula
Producer: 20190903
In:
Vascular pharmacology vol. 116
Availability: No items available.
|
|
1894.
|
|
|
1895.
|
Effect of a monoclonal antibody to PCSK9 on LDL cholesterol. [electronic resource] by
- Stein, Evan A
- Mellis, Scott
- Yancopoulos, George D
- Stahl, Neil
- Logan, Douglas
- Smith, William B
- Lisbon, Eleanor
- Gutierrez, Maria
- Webb, Cheryle
- Wu, Richard
- Du, Yunling
- Kranz, Therese
- Gasparino, Evelyn
- Swergold, Gary D
Producer: 20120402
In:
The New England journal of medicine vol. 366
Availability: No items available.
|
|
1896.
|
|
|
1897.
|
|
|
1898.
|
|
|
1899.
|
Ossabaw Pigs With a PCSK9 Gain-of-Function Mutation Develop Accelerated Coronary Atherosclerotic Lesions: A Novel Model for Preclinical Studies. [electronic resource] by
- Yuan, Fang
- Guo, Liang
- Park, Kyoung-Ha
- Woollard, John R
- Taek-Geun, Kwon
- Jiang, Kai
- Melkamu, Tamene
- Zang, Bin
- Smith, Samantha L
- Fahrenkrug, Scott C
- Kolodgie, Frank D
- Lerman, Amir
- Virmani, Renu
- Lerman, Lilach O
- Carlson, Daniel F
Producer: 20191209
In:
Journal of the American Heart Association vol. 7
Availability: No items available.
|
|
1900.
|
|